Clinical Trial Detail

NCT ID NCT03486197
Title Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

transitional cell carcinoma

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.